+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Baxter International Inc (BAX) - Product Pipeline Analysis, 2021 Update

FEATURED COMPANIES

  • Becton Dickinson and Co
  • Boston Scientific Corp
  • Gel4Med Inc
  • Hospira Inc
  • Johnson & Johnson
  • Medtronic Plc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Baxter International Inc (Baxter) is a provider of healthcare products, including dialysis in acute and chronic conditions, sterile intravenous solutions, generic injectable pharmaceuticals, parenteral nutrition therapies, infusion systems and devices, inhaled anaesthetics, and surgical hemostat and sealant products. The company’s products find application in hospitals, rehabilitation centers, kidney dialysis centers, nursing homes, besides patients at home under physician supervision. Baxter distributes products through direct sales force and also through a network of independent distributors, drug wholesalers, specialty pharmacies and other alternative site providers. The company has operations in the Americas, the Middle East, Africa, Europe and Asia-Pacific. Baxter is headquartered in Deerfield, Illinois, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.

Scope
  • The report reviews the detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Baxter International Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides a detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Becton Dickinson and Co
  • Boston Scientific Corp
  • Gel4Med Inc
  • Hospira Inc
  • Johnson & Johnson
  • Medtronic Plc
Baxter International Inc Company Overview
  • Baxter International Inc Company Snapshot
  • Baxter International Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Baxter International Inc - Pipeline Analysis Overview
  • Business Description
  • Baxter International Inc - Key Facts
  • Baxter International Inc - Major Products and Services
  • Baxter International Inc Pipeline Products by Development Stage
  • Baxter International Inc Ongoing Clinical Trials by Trial Status
Baxter International Inc Pipeline Products Overview
  • ACCUREACH
  • ACCUREACH Product Overview
  • Ambulatory Pump
  • Ambulatory Pump Product Overview
  • Arterial Everter
  • Arterial Everter Product Overview
  • Artis Dialysis System
  • Artis Dialysis System Product Overview
  • Celstat Topical Hemostatic Dressing
  • Celstat Topical Hemostatic Dressing Product Overview
  • CWP 800 Mini
  • CWP 800 Mini Product Overview
  • DurADAPT Bioimplant
  • DurADAPT Bioimplant Product Overview
  • ECOCAPTURE
  • ECOCAPTURE Product Overview
  • ENFit Enteral Syringe
  • ENFit Enteral Syringe Product Overview
  • FloSeal Matrix Hemostatic Sealant
  • FloSeal Matrix Hemostatic Sealant Product Overview
  • FloSeal Matrix Hemostatic Sealant Clinical Trial
  • GEM ZIPCLIP
  • GEM ZIPCLIP Product Overview
  • Hemopatch
  • Hemopatch Product Overview
  • Hemopatch Clinical Trial
  • Hemopatch - Dural Defects
  • Hemopatch - Dural Defects Product Overview
  • Infusion Pump
  • Infusion Pump Product Overview
  • Next Gen ICHD Monitor
  • Next Gen ICHD Monitor Product Overview
  • Next-Generation Infusion Pump - Dose Error Reduction Software
  • Next-Generation Infusion Pump - Dose Error Reduction Software Product Overview
  • Non PVC CAPD
  • Non PVC CAPD Product Overview
  • Non-DEHP Sets
  • Non-DEHP Sets Product Overview
  • Novum IQ Large Volume Pump
  • Novum IQ Large Volume Pump Product Overview
  • Novum IQ Syringe Pump
  • Novum IQ Syringe Pump Product Overview
  • Olimel N12
  • Olimel N12 Product Overview
  • Ovart 3D Biodegradable Matrix
  • Ovart 3D Biodegradable Matrix Product Overview
  • oXiris
  • oXiris Product Overview
  • oXiris Clinical Trial
  • PCA Pump
  • PCA Pump Product Overview
  • Peritoneal Dialysis Solution Generation System
  • Peritoneal Dialysis Solution Generation System Product Overview
  • Peritoneal Dialysis Solution Generation System Clinical Trial
  • PIVA Hemodynamic Monitoring System
  • PIVA Hemodynamic Monitoring System Product Overview
  • Point of Care Generation 1 System
  • Point of Care Generation 1 System Product Overview
  • Point of Care Generation 2 System
  • Point of Care Generation 2 System Product Overview
  • PrismaLung+
  • PrismaLung+ Product Overview
  • PrismaLung+ Clinical Trial
  • PrisMax 2 System
  • PrisMax 2 System Product Overview
  • ProMaxx Microsphere
  • ProMaxx Microsphere Product Overview
  • Revaclear 500
  • Revaclear 500 Product Overview
  • SEPRALAP
  • SEPRALAP Product Overview
  • Starling SV - Cardiac Risk Assessment
  • Starling SV - Cardiac Risk Assessment Product Overview
  • Synthetic Bone Graft - Spinal
  • Synthetic Bone Graft - Spinal Product Overview
  • Theranova 400 Dialyzer
  • Theranova 400 Dialyzer Product Overview
  • Theranova 400 Dialyzer Clinical Trial
  • Theranova 500 Dialyzer
  • Theranova 500 Dialyzer Product Overview
  • Theranova 500 Dialyzer Clinical Trial
  • TISSEEL
  • TISSEEL Product Overview
  • TISSEEL Clinical Trial
  • Tisseel Dura
  • Tisseel Dura Product Overview
  • URINFO 3000
  • URINFO 3000 Product Overview
  • Veritas - Cardiac Application
  • Veritas - Cardiac Application Product Overview
  • VITA IQ
  • VITA IQ Product Overview
Baxter International Inc - Key Competitors

Baxter International Inc - Key Employees
  • Baxter International Inc - Key Employee Biographies
Baxter International Inc - Locations and Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Recent Developments
  • Baxter International Inc, Recent Developments
  • Jun 15, 2021: Baxter to Host Second-Quarter 2021 Financial Results Conference Call for Investors
  • Mar 29, 2021: Baxter launches initiative to increase awareness and education in black communities about Kidney health and managing chronic kidney disease
  • Dec 03, 2020: Baxter and AdventHealth Tampa announce cost savings achieved through Intraoperative Hemostasis Management Program
  • Oct 26, 2020: ProvideGx and Baxter Healthcare secure the supply of critical shortage drug for COVID-19 patients requiring ventilation
  • Sep 18, 2020: Baxter announces support for finalization of core component of the Advancing American Kidney Health Initiative
  • Jul 29, 2020: Baxter and Ayogo announce partnership for unique digital health solutions for home dialysis
  • Jul 27, 2020: Baxter partners with VIPUN Medical for gastric monitoring system
  • Jul 09, 2020: Baxter to Host Second-Quarter 2020 Financial Results Conference Call for Investors
  • Apr 17, 2020: Baxter to Host First-Quarter 2020 Financial Results Conference Call for Investors
  • Feb 27, 2020: Baxter launches Peri-Strips Dry with secure grip technology for reliable staple line reinforcement in surgical procedures
Appendix
  • Methodology
  • About the Publisher
List of Tables
  • Baxter International Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Baxter International Inc Pipeline Products by Equipment Type
  • Baxter International Inc Pipeline Products by Indication
  • Baxter International Inc Ongoing Clinical Trials by Trial Status
  • Baxter International Inc, Key Facts
  • Baxter International Inc, Major Products and Services
  • Baxter International Inc Number of Pipeline Products by Development Stage
  • Baxter International Inc Pipeline Products Summary by Development Stage
  • Baxter International Inc Ongoing Clinical Trials by Trial Status
  • Baxter International Inc Ongoing Clinical Trials Summary
  • ACCUREACH - Product Status
  • ACCUREACH - Product Description
  • Ambulatory Pump - Product Status
  • Ambulatory Pump - Product Description
  • Arterial Everter - Product Status
  • Arterial Everter - Product Description
  • Artis Dialysis System - Product Status
  • Artis Dialysis System - Product Description
  • Celstat Topical Hemostatic Dressing - Product Status
  • Celstat Topical Hemostatic Dressing - Product Description
  • CWP 800 Mini - Product Status
  • CWP 800 Mini - Product Description
  • DurADAPT Bioimplant - Product Status
  • DurADAPT Bioimplant - Product Description
  • ECOCAPTURE - Product Status
  • ECOCAPTURE - Product Description
  • ENFit Enteral Syringe - Product Status
  • ENFit Enteral Syringe - Product Description
  • FloSeal Matrix Hemostatic Sealant - Product Status
  • FloSeal Matrix Hemostatic Sealant - Product Description
  • FloSeal Matrix Hemostatic Sealant - Blood-saving Effect of Combined Intravenous Tranexamic Acid with Topical Floseal Application, a Comparison with Intravenous Tranexamic Acid Only in Total Hip Arthroplasty
  • FloSeal Matrix Hemostatic Sealant - Efficacy of FloSeal in Endonasal Endoscopic Approach
  • FloSeal Matrix Hemostatic Sealant - Hemostatic Agent Use and Intraoperative Blood Loss in Lumbar Spine Surgery
  • GEM ZIPCLIP - Product Status
  • GEM ZIPCLIP - Product Description
  • Hemopatch - Product Status
  • Hemopatch - Product Description
  • Hemopatch - A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures on High Risk Population for Prolonged Air Leak (more than 5 Days - PAL)
  • Hemopatch - Assessment of the Usefulness of Hemopatch in Coronary Artery Bypass Graft Surgery
  • Hemopatch - Evaluating Hemopatch in Reducing Seroma Related Complications Following Axillary Lymph Node Dissection: a Pilot Study
  • Hemopatch - Exploratory Phase IV Randomized Single Blind Study Evaluating the Efficacy and Tolerability of Hemopatch in Improving Time of Hemostasis and Preventing Post-operative Complications after Hepatic Resection
  • Hemopatch - Hemopatch to Prevent Lymphatic Leak after Robotic Prostatectomy and Pelvic Lymph Node Dissection: A Randomized Controlled Trial
  • Hemopatch - Hemopatch Versus Axillary Drainage after Axillary Lymphadenectomy: Randomized, Controlled, Multicenter Clinical Study
  • Hemopatch - Phase III, Randomized, Unblinded, Controlled Clinical Trial for Evaluating the Effectiveness of the Use of the New Hemostatic Patch Hemopatch in Patients Undergoing Surgical Liver Resection
  • Hemopatch - Prospective Pilot Study for the Efficacy and Security Analysis in the Protection of Ileocolic Anastomosis Conducted in Laparoscopic Right Hemicolectomy Because of Colon Cancer, Using a Using a NHS-PEG (N-hydroxysuccinimide Functionalized Polyethylene Glycol) Coated Collagen Patch
  • Hemopatch - Randomized Multicenter Controlled Study to Evaluate the Safety and Efficacy of HEMOPATCH Compared to Routine Care for Dural Closure as Reinforcement for the Prevention of Postoperative Cerebrospinal Fluid Leakage (CSF) in Patients Undergoing Posterior Fossa Surgery
  • Hemopatch - Use of Hemopatch as a Sealant at the Pancreaticojejunostomy after Pancreatoduodenectomy to Prevent Postoperative Pancreatic Fistula
  • Hemopatch - Dural Defects - Product Status
  • Hemopatch - Dural Defects - Product Description
  • Infusion Pump - Product Status
  • Infusion Pump - Product Description
  • Next Gen ICHD Monitor - Product Status
  • Next Gen ICHD Monitor - Product Description
  • Next-Generation Infusion Pump - Dose Error Reduction Software - Product Status
  • Next-Generation Infusion Pump - Dose Error Reduction Software - Product Description
  • Non PVC CAPD - Product Status
  • Non PVC CAPD - Product Description
  • Non-DEHP Sets - Product Status
  • Non-DEHP Sets - Product Description
  • Novum IQ Large Volume Pump - Product Status
  • Novum IQ Large Volume Pump - Product Description
  • Novum IQ Syringe Pump - Product Status
  • Novum IQ Syringe Pump - Product Description
  • Olimel N12 - Product Status
  • Olimel N12 - Product Description
  • Ovart 3D Biodegradable Matrix - Product Status
  • Ovart 3D Biodegradable Matrix - Product Description
  • oXiris - Product Status
  • oXiris - Product Description
  • oXiris - A Pilot Multicentre Open-Label Randomized Controlled Trial During Treatment for Acute Kidney Injury in Critically Ill Patients with Septic Shock Comparing Two Haemofilter Membrane Devices, The An69st and the Newly Available Oxiris Haemofiltration Membrane for Early Resolution of Shock As Well As Other Clinical and Technical Performance Outcomes
  • oXiris - A Randomized, Controlled Trial to Evaluate Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) in Comparison with a Semi Selective Semipermeable Membrane (Standard AN-69) in COVID-19 Associated Acute Kidney Injury: oXAKI-COV Study
  • oXiris - Antibiotic Plasma Concentrations During Continuous Renal Replacement Therapy with a High Adsorption Membrane (oXiris)
  • oXiris - Effect of Oxiris Membrane on Microcirculation Following Cardiac Surgery Under Cardiopulmonary Bypass: A Pilot Prospective Monocentric Study (Oxicard Study)
  • oXiris - Endotoxins and Cytokines Removal During Continuous Hemofiltration with oXiris
  • oXiris - Evaluation of Oxiris Membrane as a Treatment for Ischemia-reperfusion Syndrome in Cardiogenic Shock Treated with Extracorporeal Life Support (ECMO/ECLS): A Randomized Pilot Study ECMORIX
  • oXiris - The Effects of oXiris on Systemic Inflammation, Endothelial Dysfunction and Volume Control in Cardiac Surgery Patients Undergoing Cardiopulmonary Bypass
  • PCA Pump - Product Status
  • PCA Pump - Product Description
  • Peritoneal Dialysis Solution Generation System - Product Status
  • Peritoneal Dialysis Solution Generation System - Product Description
  • Peritoneal Dialysis Solution Generation System - Improvement of Home Dialysis and to Simplify therapy Management Using On-demand Peritoneal Dialysis Solution System: US Clinical Study
  • PIVA Hemodynamic Monitoring System - Product Status
  • PIVA Hemodynamic Monitoring System - Product Description
  • Point of Care Generation 1 System - Product Status
  • Point of Care Generation 1 System - Product Description
  • Point of Care Generation 2 System - Product Status
  • Point of Care Generation 2 System - Product Description
  • PrismaLung+ - Product Status
  • PrismaLung+ - Product Description
  • PrismaLung+ - A Post-market Study of Performance and Safety of Low-flow Extracorporeal Carbon Dioxide Removal Using PrismaLung+ in Patients with Mild to Moderate Acute Respiratory Distress Syndrome
  • PrisMax 2 System - Product Status
  • PrisMax 2 System - Product Description
  • ProMaxx Microsphere - Product Status
  • ProMaxx Microsphere - Product Description
  • Revaclear 500 - Product Status
  • Revaclear 500 - Product Description
  • SEPRALAP - Product Status
  • SEPRALAP - Product Description
  • Starling SV - Cardiac Risk Assessment - Product Status
  • Starling SV - Cardiac Risk Assessment - Product Description
  • Synthetic Bone Graft - Spinal - Product Status
  • Synthetic Bone Graft - Spinal - Product Description
  • Theranova 400 Dialyzer - Product Status
  • Theranova 400 Dialyzer - Product Description
  • Theranova 400 Dialyzer - A Multicentre, Open-label, Prospective, Randomized Study to Explore the Morbimortality in Patients Dialyzed with the Theranova HDx in Comparison to On-Line - Hemodiafiltration (Study MoTHER HDx)
  • Theranova 400 Dialyzer - A Randomized, Open-label, Cross Over Group, Single-centre Controlled Study To Evaluate The Clinical Performance Of Medium Cut-off Membrane Dialyzer Compared with High Flux Dialyzer in Removing Beta-2- Microglobulin Among Patients with End-stage Kidney Disease On Chronic Haemodialysis
  • Theranova 400 Dialyzer - Effect of Hemodiafiltration Plus MCOs on Uremic Toxins Removal
  • Theranova 400 Dialyzer - Evaluation of Effectiveness, Safety and Health-related Quality of Life Associated with HDx Therapy Enabled by THERANOVA in Subjects with End-stage Renal Disease: A Colombian Study
  • Theranova 400 Dialyzer - Long-term Effects of Expanded Hemodialysis in Reduction of Large Middle Molecules in Chronic Hemodialysis Patients: Potential Benefits to the Prevention of Sarcopenia
  • Theranova 400 Dialyzer - Medium-term Modulation of the Inflammatory Profile by Medium-cut Off Membranes in Patients with End Stage Renal Disease
  • Theranova 400 Dialyzer - Molecular and Cellular Mechanism of Vascular Ageing in Chronic Kidney Disease: Role of Theranova Dialyzer on Mineral Metabolism Disorder, Oxidative Stress, and Vascular Calcification
  • Theranova 400 Dialyzer - Multi-center, Prospective, Randomized Controlled Study in US to Evaluate the Effectiveness and Safety of THERANOVA
  • Theranova 400 Dialyzer - Randomized Controlled Trial of Theranova Versus High-flux Dialyzer on Preservation of Residual Renal Function in Incident Hemodialysis Patients
  • Theranova 400 Dialyzer - The Comparison of Expanded Dialysis with Theranova Dialyzer with Conventional High-flux Hemodialysis
  • Theranova 500 Dialyzer - Product Status
  • Theranova 500 Dialyzer - Product Description
  • Theranova 500 Dialyzer - A Multicentre, Open-label, Prospective, Randomized Study to Explore the Morbimortality in Patients Dialyzed with the Theranova HDx in Comparison to On-Line - Hemodiafiltration (Study MoTHER HDx)
  • Theranova 500 Dialyzer - Medium-term Modulation of the Inflammatory Profile by Medium-cut Off Membranes in Patients with End Stage Renal Disease
  • Theranova 500 Dialyzer - Molecular and Cellular Mechanism of Vascular Ageing in Chronic Kidney Disease: Role of Theranova Dialyzer on Mineral Metabolism Disorder, Oxidative Stress, and Vascular Calcification
  • Theranova 500 Dialyzer - The Comparison of Expanded Dialysis with Theranova Dialyzer with Conventional High-flux Hemodialysis
  • TISSEEL - Product Status
  • TISSEEL - Product Description
  • TISSEEL - Modified Muller's Muscle-conjunctival Resection Internal Ptosis Repair Using Fibrin Glue
  • TISSEEL - The Use of Fibrin Glue Sealant (Tisseel) as a Reinforcement of Esophagojejunal Anastomoses will Decrease the Rate of Anastomotic Leak
  • Tisseel Dura - Product Status 7
  • Tisseel Dura - Product Description 7
  • URINFO 3000 - Product Status
  • URINFO 3000 - Product Description
  • Veritas - Cardiac Application - Product Status
  • Veritas - Cardiac Application - Product Description
  • VITA IQ - Product Status
  • VITA IQ - Product Description
Baxter International Inc, Key Employees
  • Baxter International Inc, Key Employee Biographies
  • Baxter International Inc, Subsidiaries 7
  • Baxter International Inc, Joint Venture
  • Glossary
List of Figures
  • Baxter International Inc Pipeline Products by Equipment Type
  • Baxter International Inc Pipeline Products by Development Stage
  • Baxter International Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
  • Fresenius Medical Care AG & Co KGaA
  • Boston Scientific Corp
  • Medtronic Plc
  • Gel4Med Inc
  • Hospira Inc
  • Becton Dickinson and Co
  • NxStage Medical Inc
  • Johnson & Johnson
Note: Product cover images may vary from those shown
Adroll
adroll